Astragalus has 4 headline claims, and the honest ranking puts kidney support first and cancer last. The gap between those 2 is large.
This article grades each claim by what the trials actually measured, including the 2 studies most often misread: a Cochrane kidney review with 1323 participants and a chemotherapy meta-analysis covering 2815 patients.
Quick Answer: What Are the Real Benefits?
Adjunctive kidney support has the most data: 22 pooled studies show proteinuria down 0.53 g per 24 hours, albumin up 3.55 g/L and haemoglobin up 9.51 g/L. Immune effects rest on small trials and tradition. The cancer literature studied herbal combinations alongside chemotherapy, never astragalus alone.
Key Takeaways
- Pooled kidney data cover 22 studies and 1323 total participants.
- Serum albumin rose 3.55 g/L across 9 of those studies.
- That chemotherapy meta-analysis covered 34 trials and 2815 total patients.
- Its design tested 2 things together: herbal combinations plus platinum chemotherapy.
- Oral astragalus evidence rests on only 4 kidney trials total.
Related Products
How to Read an Astragalus Claim
Astragalus research has an unusual shape: a large body of Chinese hospital trials with low methodological quality, plus a handful of small Western studies. Ignoring the first group is lazy and quoting it uncritically is worse.
- Tier 1: Adjunctive kidney trials, pooled but low quality.
- Tier 2: Chemotherapy support, herbal combinations only.
- Tier 3: Immune markers, small human trials and tradition.
- Tier 4: Anti-ageing and telomere claims, preclinical.
The background on the root itself is in what the root actually is, including why the species name matters.
Benefit 1: Kidney and Protein Markers
This is the strongest column. A Cochrane review pooled 22 randomized and quasi-randomized studies in 1323 participants and reported consistent improvements in several markers used to follow chronic kidney disease.[1]Astragalus (a traditional Chinese medicine) for treating chronic kidney disease — Cochrane Database of Systematic Reviews View source
| Marker | Pooled change | How to read it |
|---|---|---|
| 24-hour proteinuria | -0.53 g | Meaningful direction, high heterogeneity |
| Haemoglobin | +9.51 g/L | Clearer in dialysis patients |
| Serum albumin | +3.55 g/L | Seen in dialysis and non-dialysis groups |
| Systolic blood pressure | -16.65 mmHg | Only 2 studies, 77 participants |
| Dialysis or death | Not reported | The outcomes that matter most |
Reviewers described study quality as low, with 6 of 22 studies at high risk of bias and the rest unclear. Promising and unproven are both accurate descriptions.
Benefit 2: Diabetic Kidney Disease
A larger systematic review looked specifically at diabetic kidney disease and pooled 66 studies covering 4785 participants, with 1 crucial detail buried in the methods.[2]Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis — Journal of Ethnopharmacology View source
- Injection trials: 32 for albuminuria, 26 for proteinuria, 32 for creatinine.
- Oral trials: 4, with 236 participants combined.
- Heterogeneity: 73 to 97 percent, which is very high.
- Adverse events: Similar between astragalus and control groups.
If you are buying capsules, that oral row is your evidence base, not the injection rows. The full picture is in astragalus for kidney health.
Benefit 3: The Chemotherapy Studies
This is the most misrepresented literature in the entire herb aisle, so the design matters more than the numbers. A 2006 meta-analysis in the Journal of Clinical Oncology examined 34 randomized trials in 2815 patients with advanced non-small-cell lung cancer.[3]Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials — Journal of Clinical Oncology View source
| What was compared | Result |
|---|---|
| Astragalus-based herbal combination PLUS platinum chemotherapy | Reduced risk of death at 12 months, RR 0.67 |
| Versus platinum chemotherapy alone | Improved tumour response, RR 1.34 |
| Astragalus alone as a cancer treatment | Never tested in these trials |
| Herb quality and formula | Varied between studies |
Read row 3 twice. Nobody in those 34 trials took astragalus instead of chemotherapy, and anyone with cancer should be talking to their oncology team rather than to a supplement label.
Benefit 4: Immune Function
The immune claim is the reason most Western customers buy astragalus and the thinnest of the 4 in human data. What exists includes a randomized trial in exercise-induced immunosuppression and a trial in seasonal allergic rhinitis.[4]Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis — Phytotherapy Research View source
- Traditional framing: A months-long tonic, not an acute remedy.
- Mechanism: Astragalus polysaccharides studied as immunomodulators.
- Human outcomes: Small trials, no large cold-prevention study.
- Caution: Stimulation is unwanted in autoimmune disease.
What that means in practice, and how it differs from echinacea, is covered in astragalus for immune support.
What Is Not Supported
Three claims deserve a flat answer, because each takes a real finding and stretches it past anything a person can rely on.
- Reverses ageing: Based on preclinical telomerase work, not outcomes.
- Cures kidney disease: Trials were adjunctive, and quality was low.
- Replaces medication: No trial tested astragalus instead of treatment.
- Works within days: Traditional use runs over months, not a weekend.
Buying with the correct expectation is most of the value here, and a single-ingredient product like our 1000 mg astragalus root at least makes the amount you are taking unambiguous.
Frequently Asked Questions
What does astragalus do to your body? +
In pooled kidney trials it reduced proteinuria by 0.53 g per 24 hours and raised haemoglobin by 9.51 g/L as an add-on to conventional care. Mechanistically its polysaccharides are studied as immune modulators rather than as a stimulant you feel.
Is astragalus proven to work? +
Partly, and honestly labelled: 22 pooled kidney studies show consistent marker improvements with low study quality, and the 2 outcomes that matter most were never reported. Calling it proven would overstate the evidence by a wide margin.
Does astragalus help with cancer? +
No trial has tested astragalus as a cancer treatment. The 2006 meta-analysis of 34 trials in 2815 patients studied astragalus-based herbal combinations given alongside platinum chemotherapy, which is an entirely different question.
Is astragalus good for anaemia? +
Pooled data show haemoglobin rising 9.51 g/L overall and 11.20 g/L in haemodialysis patients, across 4 studies with 222 participants. That is an adjunctive finding in kidney disease, not a treatment for iron-deficiency anaemia.
Does astragalus lower blood pressure? +
Two studies with 77 participants reported systolic pressure down 16.65 mmHg and diastolic down 6.02 mmHg. That is a small evidence base, and anyone on blood pressure medication should treat it as a reason to monitor rather than to adjust.
Does astragalus help allergies? +
One trial has examined astragalus in seasonal allergic rhinitis, which is 1 study rather than an established use. Immune-modulating herbs also warrant caution in anyone with autoimmune conditions, so it is not a free choice.
Is astragalus an adaptogen? +
It is often listed as 1, though its research profile looks nothing like ashwagandha's stress and cortisol work. Astragalus is better described as an immune and kidney tonic than as a stress adaptogen.
Are astragalus benefits immediate or cumulative? +
Traditional use runs over months, and the kidney trials typically ran 8 weeks or longer with a 2024 study running 48 weeks. Nothing here supports judging it after 1 or 2 weeks.
Does astragalus boost energy? +
In Chinese medicine it is a qi tonic, often translated as energy, but not 1 controlled trial has measured fatigue or energy as a primary outcome. Treat that claim as traditional rather than tested.
Is the injection research relevant to capsules? +
Only partly. In the 66-study diabetic kidney review, 32 trials used injection for albuminuria while just 4 used oral preparations. Capsule buyers should weight those 4 trials, not the intravenous ones.
Can astragalus replace my kidney medication? +
No. All 22 pooled trials added astragalus to conventional therapy rather than replacing it, and the outcomes that would justify replacement, such as time to dialysis, were not measured at all. That decision belongs to a nephrologist.
Related Reading
Related Products
